Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein

Background: Head and neck squamous cell carcinoma (HNSCC) is one most prevalent cancers among worldwide. Aim of this study was to evaluate possible effect of bevacizumab, a vascular endothelial growth (VEGF) factor monoclonal antibody on HNSCC cells in vitro to evaluate angiogenic profile changes. M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Hematol Oncol Stem Cell Res
Main Authors: Heydar, Hossein, Mansouri, Kamran, Norooznezhad, Maryam, Norooznezhad, Fatemeh, Mohamadnia, Abdolreza, Bahrami, Naghmeh
Formato: Artigo
Idioma:Inglês
Publicado em: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6141426/
https://ncbi.nlm.nih.gov/pubmed/30233776
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados